Compo-Q: New small molecules for the treatment of prion and neurodegenerative diseases(e.g. Alzheimer’s disease)

Scientists at the University of Duesseldorf and the University of Erlangen have developed new small molecules which can be used for the treatment of diseases characterized by the presence of misfolded

proteins. Examples for such medical conditions are prion diseases, e.g. CJD, as well as neurodegenerative (e.g. Alzheimer’s disease) or neuropsychiatric diseases. Compo-Q have a structural relationship to quinacrine which is considered to be one of the most promising candidate for the clinical therapy of prion diseases. In Compo-Q the “modified quinacrine” is covalently linked to a derivative of another substance which has been proven effective against prion diseases in vitro.

Further Information: PDF

PROvendis GmbH
Phone: +49 (0)208/94105 0

Contact
Dipl.-Ing. Alfred Schillert

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

New theory reveals the shape of a single photon

A new theory, that explains how light and matter interact at the quantum level has enabled researchers to define for the first time the precise shape of a single photon….

Perovskite research boosts solar cell efficiency and product life

An international team led by the University of Surrey with Imperial College London have identified a strategy to improve both the performance and stability for solar cells made out of…

Neuroscientists discover how the brain slows anxious breathing

Salk scientists identify brain circuit used to consciously slow breathing and confirm this reduces anxiety and negative emotions. Deep breath in, slow breath out… Isn’t it odd that we can…